vs
MetroCity Bankshares, Inc.（MCBS）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是MetroCity Bankshares, Inc.的1.6倍（$69.8M vs $43.7M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 50.5%，领先333.5%），MetroCity Bankshares, Inc.同比增速更快（23.6% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 15.7%）
MetroCity Bankshares, Inc.旗下的大都会城市银行是一家韩裔美国人创办的银行，总部位于佐治亚州多拉维尔，提供个人及商业银行服务。它是总部不在加利福尼亚州洛杉矶的最大韩美系银行，目前在德克萨斯、纽约、新泽西、弗吉尼亚、佐治亚、阿拉巴马和佛罗里达共设有19家分行。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
MCBS vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.6倍
$43.7M
营收增速更快
MCBS
高出2.4%
21.2%
净利率更高
RIGL
高出333.5%
50.5%
两年增速更快
RIGL
近两年复合增速
15.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $43.7M | $69.8M |
| 净利润 | $18.1M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 52.8% | 33.2% |
| 净利率 | 50.5% | 384.0% |
| 营收同比 | 23.6% | 21.2% |
| 净利润同比 | 11.7% | 1769.2% |
| 每股收益（稀释后） | $0.69 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MCBSRIGL
| Q4 25 | $43.7M | $69.8M | ||
| Q3 25 | $38.0M | $69.5M | ||
| Q2 25 | $37.9M | $101.7M | ||
| Q1 25 | $36.0M | $53.3M | ||
| Q4 24 | $35.4M | $57.6M | ||
| Q3 24 | $36.9M | $55.3M | ||
| Q2 24 | $36.3M | $36.8M | ||
| Q1 24 | $32.7M | $29.5M |
净利润MCBSRIGL
| Q4 25 | $18.1M | $268.1M | ||
| Q3 25 | $17.3M | $27.9M | ||
| Q2 25 | $16.8M | $59.6M | ||
| Q1 25 | $16.3M | $11.4M | ||
| Q4 24 | $16.2M | $14.3M | ||
| Q3 24 | $16.7M | $12.4M | ||
| Q2 24 | $16.9M | $-1.0M | ||
| Q1 24 | $14.6M | $-8.2M |
毛利率MCBSRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率MCBSRIGL
| Q4 25 | 52.8% | 33.2% | ||
| Q3 25 | 62.8% | 40.9% | ||
| Q2 25 | 62.4% | 60.1% | ||
| Q1 25 | 61.3% | 23.9% | ||
| Q4 24 | 58.9% | 28.9% | ||
| Q3 24 | 61.4% | 25.4% | ||
| Q2 24 | 64.4% | 1.2% | ||
| Q1 24 | 62.6% | -23.6% |
净利率MCBSRIGL
| Q4 25 | 50.5% | 384.0% | ||
| Q3 25 | 45.5% | 40.2% | ||
| Q2 25 | 44.4% | 58.6% | ||
| Q1 25 | 45.3% | 21.5% | ||
| Q4 24 | 54.0% | 24.9% | ||
| Q3 24 | 45.3% | 22.5% | ||
| Q2 24 | 46.7% | -2.8% | ||
| Q1 24 | 44.8% | -27.9% |
每股收益（稀释后）MCBSRIGL
| Q4 25 | $0.69 | $14.11 | ||
| Q3 25 | $0.67 | $1.46 | ||
| Q2 25 | $0.65 | $3.28 | ||
| Q1 25 | $0.63 | $0.63 | ||
| Q4 24 | $0.64 | $0.82 | ||
| Q3 24 | $0.65 | $0.70 | ||
| Q2 24 | $0.66 | $-0.06 | ||
| Q1 24 | $0.57 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $383.7M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $544.2M | $391.5M |
| 总资产 | $4.8B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资MCBSRIGL
| Q4 25 | $383.7M | $155.0M | ||
| Q3 25 | $227.2M | $137.1M | ||
| Q2 25 | $286.0M | $108.4M | ||
| Q1 25 | $285.1M | $77.1M | ||
| Q4 24 | $249.9M | $77.3M | ||
| Q3 24 | $291.2M | $61.1M | ||
| Q2 24 | $327.9M | $49.1M | ||
| Q1 24 | $258.8M | $49.5M |
总债务MCBSRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益MCBSRIGL
| Q4 25 | $544.2M | $391.5M | ||
| Q3 25 | $445.9M | $117.6M | ||
| Q2 25 | $436.1M | $81.9M | ||
| Q1 25 | $428.0M | $18.6M | ||
| Q4 24 | $421.4M | $3.3M | ||
| Q3 24 | $407.2M | $-14.6M | ||
| Q2 24 | $407.2M | $-29.9M | ||
| Q1 24 | $396.6M | $-31.7M |
总资产MCBSRIGL
| Q4 25 | $4.8B | $513.6M | ||
| Q3 25 | $3.6B | $242.5M | ||
| Q2 25 | $3.6B | $206.7M | ||
| Q1 25 | $3.7B | $176.0M | ||
| Q4 24 | $3.6B | $164.0M | ||
| Q3 24 | $3.6B | $139.4M | ||
| Q2 24 | $3.6B | $128.4M | ||
| Q1 24 | $3.6B | $126.5M |
负债/权益比MCBSRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $37.7M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $37.0M | — |
| 自由现金流率自由现金流/营收 | 84.7% | — |
| 资本支出强度资本支出/营收 | 1.5% | — |
| 现金转化率经营现金流/净利润 | 2.08× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $79.4M | — |
8季度趋势，按日历期对齐
经营现金流MCBSRIGL
| Q4 25 | $37.7M | $22.0M | ||
| Q3 25 | $16.5M | $24.0M | ||
| Q2 25 | $14.5M | $30.5M | ||
| Q1 25 | $11.9M | $-893.0K | ||
| Q4 24 | $63.5M | $14.5M | ||
| Q3 24 | $-11.5M | $21.7M | ||
| Q2 24 | $19.4M | $302.0K | ||
| Q1 24 | $36.4M | $-5.0M |
自由现金流MCBSRIGL
| Q4 25 | $37.0M | — | ||
| Q3 25 | $16.2M | — | ||
| Q2 25 | $14.3M | — | ||
| Q1 25 | $11.8M | — | ||
| Q4 24 | $62.2M | — | ||
| Q3 24 | $-11.8M | — | ||
| Q2 24 | $19.0M | — | ||
| Q1 24 | $36.1M | — |
自由现金流率MCBSRIGL
| Q4 25 | 84.7% | — | ||
| Q3 25 | 42.7% | — | ||
| Q2 25 | 37.8% | — | ||
| Q1 25 | 32.9% | — | ||
| Q4 24 | 175.8% | — | ||
| Q3 24 | -31.9% | — | ||
| Q2 24 | 52.4% | — | ||
| Q1 24 | 110.6% | — |
资本支出强度MCBSRIGL
| Q4 25 | 1.5% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 3.6% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 0.7% | — |
现金转化率MCBSRIGL
| Q4 25 | 2.08× | 0.08× | ||
| Q3 25 | 0.95× | 0.86× | ||
| Q2 25 | 0.86× | 0.51× | ||
| Q1 25 | 0.73× | -0.08× | ||
| Q4 24 | 3.91× | 1.01× | ||
| Q3 24 | -0.69× | 1.75× | ||
| Q2 24 | 1.14× | — | ||
| Q1 24 | 2.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
